Global X Management Company’s PDL BioPharma, Inc. PDLI Stock Holding History

Global X Management Company’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,218,505	Closed	-$7.85M	–	943
2015 Q4	$7.85M	Sell	2,218,505 -65,508	-3%	-$274K	0.53%	52
2015 Q3	$11.5M	Sell	2,284,013 -151,398	-6%	-$868K	0.86%	16
2015 Q2	$15.7M	Buy	2,435,411 +195,518	+9%	+$1.31M	0.86%	20
2015 Q1	$15.8M	Buy	2,239,893 +1,050,607	+88%	+$7.61M	0.9%	20
2014 Q4	$9.17M	Sell	1,189,286 -32,898	-3%	-$260K	0.51%	57
2014 Q3	$9.13M	Buy	1,222,184 +61,608	+5%	+$572K	0.5%	75
2014 Q2	$11.2M	Buy	1,160,576 +182,975	+19%	+$1.63M	0.65%	41
2014 Q1	$8.12M	Sell	977,601 -324,596	-25%	-$2.78M	0.55%	97
2013 Q4	$11M	Buy	1,302,197 +128,340	+11%	+$1.08M	0.93%	13
2013 Q3	$9.36M	Buy	1,173,857 +113,817	+11%	+$915K	1.11%	15
2013 Q2	$8.18M	Buy	+1,060,040	New	+$8.27M	1.34%	13

Other funds holding PDLI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Global X Management Company's PDLI Position: Q1 2016 in Review

Global X Management Company sold out of PDL BioPharma, Inc. (PDLI) in Q1 2016, closing a stake of 2,218,505 shares — an estimated $7.85M sold.

Global X Management Company first reported a position in PDLI in Q2 2013 and held it in 11 quarters. The position peaked at $15.8M in Q1 2015. 195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

Global X Management Company reported no remaining PDL BioPharma, Inc. position as of Q1 2016 after selling out during the quarter.
Global X Management Company sold 2,218,505 PDL BioPharma, Inc. shares in Q1 2016, an estimated $7.85M.
Global X Management Company first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 11 quarters.
Global X Management Company's PDL BioPharma, Inc. position peaked at $15.8M in Q1 2015.
195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Global X Management Company's 13F filing for Q1 2016, filed 6 May 2016.